131 related articles for article (PubMed ID: 6890374)
1. Double-blind comparison of the hypotensive, sedative and salivary flow effects of lofexidine and clonidine in normal subjects.
Dollery CT; Reid JL
Arzneimittelforschung; 1982; 32(8a):984-7. PubMed ID: 6890374
[TBL] [Abstract][Full Text] [Related]
2. Animal experiments on the cardiovascular effects of lofexidine.
Graf E; Doppelfeld IS; Prop G
Arzneimittelforschung; 1982; 32(8a):941-55. PubMed ID: 6890368
[TBL] [Abstract][Full Text] [Related]
3. Characteristics of lofexidine in pharmacological screening.
Wagener HH; Genthe H
Arzneimittelforschung; 1982; 32(8a):918-23. PubMed ID: 6890365
[TBL] [Abstract][Full Text] [Related]
4. An alternative method of assessing changes in salivary flow: comparison of the effects of clonidine and tiamenidine (HOE 440).
Findlay D; Lawrence JR
Eur J Clin Pharmacol; 1978 Dec; 14(4):231-5. PubMed ID: 729618
[TBL] [Abstract][Full Text] [Related]
5. Animal experiments on the safety pharmacology of lofexidine.
Graf E; Sieck A; Wenzl H; Winkelmann J
Arzneimittelforschung; 1982; 32(8a):931-40. PubMed ID: 6890367
[TBL] [Abstract][Full Text] [Related]
6. [Oral premedication with clonidine as an alternative in dental practice. The effects on the pain threshold, blood pressure and salivary flow].
Fanini D; Poglio M; Marci MC; Iovinelli G; Antenucci F
Minerva Stomatol; 1998 Sep; 47(9):453-64. PubMed ID: 9835755
[TBL] [Abstract][Full Text] [Related]
7. Bioavailability and clinical effects of three brands of clonidine: the relationship between plasma level and effect.
Kanto J; Allonen H; Hiltunen R; Marvola M; Mäntylä R
Int J Clin Pharmacol Ther Toxicol; 1982 Mar; 20(3):118-21. PubMed ID: 7068284
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetic and concentration-effect relationships of clonidine in essential hypertension.
Wing LM; Reid JL; Davies DS; Neill EA; Tippett P; Dollery CT
Eur J Clin Pharmacol; 1977 Dec; 12(6):463-9. PubMed ID: 598422
[TBL] [Abstract][Full Text] [Related]
9. Toxicology of the combination lofexidine/hydrochlorothiazide.
Friehe H; Fontaine R; Gibson JP; Larson EJ; Sells DM
Arzneimittelforschung; 1982; 32(8a):966-71. PubMed ID: 6890371
[TBL] [Abstract][Full Text] [Related]
10. Pharmacological properties of 2-(2-chloro-p-toluidino)-2-imidazoline-nitrate (tolonidine), a new antihypertensive agent. III. Action on the secretions of the digestive tract and on the central nervous system, acute toxicity.
Cosnier D; Hache J; Labrid C; Streichenberger G
Arzneimittelforschung; 1975; 25(12):1926-33. PubMed ID: 3186
[TBL] [Abstract][Full Text] [Related]
11. The central hypotensive effect of clonidine. Studies in tetraplegic subjects.
Reid JL; Wing LM; Mathias CJ; Frankel HL; Neill E
Clin Pharmacol Ther; 1977 Apr; 21(4):375-81. PubMed ID: 321174
[TBL] [Abstract][Full Text] [Related]
12. Hemodynamic and humoral effects at rest and after head-up tilt tests during 24-hour infusion of a new nitrate ester, ITF 296, compared with ISDN and placebo in healthy volunteers: a double-blind, randomized, within-subject study.
Sardina M; Warrington SJ; Boyce M; Johnston A; Bianchini C
J Cardiovasc Pharmacol; 1995; 26 Suppl 4():S80-90. PubMed ID: 8839231
[TBL] [Abstract][Full Text] [Related]
13. Opiate withdrawal using lofexidine, a clonidine analogue with fewer side effects.
Washton AM; Resnick RB; Geyer G
J Clin Psychiatry; 1983 Sep; 44(9):335-7. PubMed ID: 6355070
[TBL] [Abstract][Full Text] [Related]
14. Centrally acting antihypertensive agents: a comparison of lofexidine with clonidine.
Schultz HS; Chretien SD; Brewer DD; Eltorai MI; Weber MA
J Clin Pharmacol; 1981; 21(2):65-71. PubMed ID: 7229119
[TBL] [Abstract][Full Text] [Related]
15. Lofexidine and clonidine in moderate essential hypertension.
Wilkins LH; Winternitz SR; Oparil S; Smith LR; Dustan HP
Clin Pharmacol Ther; 1981 Dec; 30(6):752-07. PubMed ID: 7030578
[TBL] [Abstract][Full Text] [Related]
16. Comparative efficacy and safety of lofexidine and clonidine in mild to moderately severe systemic hypertension.
Lopez LM; Mehta JL
Am J Cardiol; 1984 Mar; 53(6):787-90. PubMed ID: 6702628
[TBL] [Abstract][Full Text] [Related]
17. Hemodynamic and cognitive effects of lofexidine and methadone coadministration: a pilot study.
Schroeder JR; Schmittner J; Bleiberg J; Epstein DH; Krantz MJ; Preston KL
Pharmacotherapy; 2007 Aug; 27(8):1111-9. PubMed ID: 17655511
[TBL] [Abstract][Full Text] [Related]
18. Antihypertensive effects of a new transdermal delivery system for clonidine in genetic and experimental hypertensive rats.
Ishii R; Tagawa T; Ishida T; Naruse T
Arzneimittelforschung; 1996 Mar; 46(3):261-8. PubMed ID: 8901146
[TBL] [Abstract][Full Text] [Related]
19. Acute, subacute and chronic toxicity/Carcinogenicity of lofexidine.
Tsai TH; Beitman RE; Gibson JP; Larson EJ; Friehe H; Fontaine R
Arzneimittelforschung; 1982; 32(8a):955-62. PubMed ID: 6890369
[TBL] [Abstract][Full Text] [Related]
20. Naloxone does not affect the cardiovascular, sedative or neurohormonal effects of clonidine in normal and hypertensive man.
Mathias CJ; da Costa DF; Cleary JC; Peart S
J Hypertens Suppl; 1985 Dec; 3(4):S77-9. PubMed ID: 3007707
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
